Federal inspectors found Valley View Home failed to properly assess and treat resident behaviors, instead relying on repeated medication increases that proved ineffective. The resident, identified as a woman who experienced worsening behaviors during menstruation, was hospitalized on January 6 and never returned to the 59230 facility.
The medication escalation was dramatic. Between December 9 and January 6, staff increased the resident's Seroquel from 100 milligrams twice daily to 200 milligrams three times daily — a jump from 200 milligrams to 600 milligrams per day in less than a month.
Records show the facility had been adjusting her psychiatric medications since at least July 2024. She received fluoxetine, an antidepressant, starting September 17, 2024. Staff added Abilify, another antipsychotic, increasing it from 10 milligrams twice daily to 15 milligrams twice daily by July 15, 2025.
The woman also received Seroquel from June 4 through November 7, 2025, at 50 milligrams twice daily. After a brief break, staff restarted it December 9 at 100 milligrams three times daily, then doubled the dose to 200 milligrams three times daily by December 30.
For one week in July, she also received Haloperidol, yet another antipsychotic, at 5 milligrams nightly. Staff kept additional psychiatric drugs available as needed: more Seroquel, Haloperidol, and Ativan for anxiety.
Despite this pharmaceutical barrage, behavior documentation showed little to no improvement. Inspectors noted the resident's Seroquel "was changed multiple times with little to no effect, as evidenced by her behavior documentation."
The facility's care plan, dated December 28, 2025, acknowledged her challenging behaviors but offered only basic interventions. Staff planned to assess her for pain during agitated episodes and provide different staff members when she became upset.
The plan recognized her menstrual cycle triggered worse behaviors. Proposed comfort measures included aromatherapy and warm towels when she appeared agitated.
But the care plan failed critical elements. Inspectors found no attempts to identify new contributing factors to her behaviors. It showed no new interventions to prevent the episodes or protect her during them. Most significantly, it failed to specify what level of monitoring and oversight she needed to remain safe.
The facility maintained behavior review documents from July 1, 2025, through January 9, 2026, tracking the medication changes alongside ongoing behavioral incidents. The pattern was clear: each medication adjustment failed to resolve the underlying issues driving her aggressive episodes.
Federal regulations require nursing homes to identify and address the root causes of resident behaviors before resorting to psychiatric medications. The approach should emphasize non-drug interventions and careful monitoring when medications are necessary.
Instead, Valley View Home appeared to treat each behavioral episode as a dosing problem rather than investigating environmental, medical, or psychological triggers that might be addressed through other means.
The resident's hospitalization on January 6 marked the end of her stay at Valley View Home. By the time federal inspectors completed their complaint investigation on January 29, she had not returned to the facility.
The case illustrates a broader problem in nursing home behavioral health care: the reflexive use of powerful psychiatric medications without adequate assessment of their effectiveness or exploration of alternatives. For this Glasgow woman, six months of escalating drug therapy ended not in stabilization, but in hospitalization and displacement from her home.
The inspection classified the violation as minimal harm with few residents affected, but for the woman at the center of the case, the consequences were life-altering. She left Valley View Home not because her behaviors improved, but because the facility's approach had reached its limits.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Valley View Home from 2026-01-29 including all violations, facility responses, and corrective action plans.